NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pacific GeneTech

Pacific GeneTech

Private
Rogers, ArkansasHealthcare & Life Scienceshttps://pacificgenetech.com/index.html

Last Round

Series A

Aug 24, 2022

Total Funding Raised

$10M

Company Overview

Pacific GeneTech is a biotechnology company that develops and commercializes next-generation vaccines and adjuvant technologies for animal health and food safety.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

animal healthveterinary vaccinesbiotechnologyvaccine platformadjuvant technologybiologicsanimal biotechfood safetyvaccine licensingveterinary medicinevector technologymannosylated chitosananimal health techpharma licensingvaccine R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pacific GeneTech Comparables

Compare Pacific GeneTech with similar companies based on industry and business-model similarity.

Pacific GeneTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Endovac Animal Health
78%
Aptimmune Biologics, Inc.
77%
Biogénesis Bagó
68%

Pacific GeneTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 24, 2022
Early FundingMay 24, 2020

Key People

Founding team and executive leadership

Christopher W. Kennedy

Chief Executive Officer

Executive Team

Pacific GeneTech Investors

Notable investors and investment history

Pacific GeneTech investors
InvestorRounds
AVG VenturesEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2026

    Monthly visitors grew 105% MoM.

  • Jan 26, 2026

    Monthly visitors grew 121% MoM, reaching 1K.

Pacific GeneTech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pacific GeneTech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pacific GeneTech's valuation, stock price, and market status.

Firmographic Details

HeadquartersRogers, Arkansas
Employee Range9
Year Founded2009
Last FundingAug 24, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.